Search

Christopher R. Stone

Examiner (ID: 15088, Phone: (571)270-3494 , Office: P/1628 )

Most Active Art Unit
1628
Art Unit(s)
1609, 1628, 4173, 1614
Total Applications
750
Issued Applications
250
Pending Applications
42
Abandoned Applications
457

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20129110 [patent_doc_number] => 12371412 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-29 [patent_title] => Methods of preparing cannabinoids or derivatives thereof [patent_app_type] => utility [patent_app_number] => 18/403509 [patent_app_country] => US [patent_app_date] => 2024-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15167 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18403509 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/403509
Methods of preparing cannabinoids or derivatives thereof Jan 2, 2024 Issued
Array ( [id] => 19464082 [patent_doc_number] => 20240317751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => PURINONE DERIVATIVE HYDROCHLORIDE [patent_app_type] => utility [patent_app_number] => 18/396017 [patent_app_country] => US [patent_app_date] => 2023-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18396017 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/396017
PURINONE DERIVATIVE HYDROCHLORIDE Dec 25, 2023 Pending
Array ( [id] => 19389327 [patent_doc_number] => 20240279197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => NRF2 ACTIVATOR [patent_app_type] => utility [patent_app_number] => 18/545312 [patent_app_country] => US [patent_app_date] => 2023-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31899 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18545312 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/545312
NRF2 ACTIVATOR Dec 18, 2023 Abandoned
Array ( [id] => 19081830 [patent_doc_number] => 20240108631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => TREATMENT FOR CELLULITIS AND PRE-OPERATIVE TREATMENT [patent_app_type] => utility [patent_app_number] => 18/535036 [patent_app_country] => US [patent_app_date] => 2023-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535036 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/535036
Treatment for cellulitis and pre-operative treatment Dec 10, 2023 Issued
Array ( [id] => 19599451 [patent_doc_number] => 20240390331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => ORAL BENDAMUSTINE FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/532962 [patent_app_country] => US [patent_app_date] => 2023-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18532962 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/532962
ORAL BENDAMUSTINE FORMULATIONS Dec 6, 2023 Abandoned
Array ( [id] => 19135521 [patent_doc_number] => 11970451 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-04-30 [patent_title] => 6-(3-hydroxyphenyl)-2-methoxy-4-(3-methylphenyl)nicotinonitrile as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/532000 [patent_app_country] => US [patent_app_date] => 2023-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4030 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18532000 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/532000
6-(3-hydroxyphenyl)-2-methoxy-4-(3-methylphenyl)nicotinonitrile as an antimicrobial compound Dec 6, 2023 Issued
Array ( [id] => 19096358 [patent_doc_number] => 20240115585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => METHODS OF TREATING CANCER [patent_app_type] => utility [patent_app_number] => 18/524489 [patent_app_country] => US [patent_app_date] => 2023-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17839 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18524489 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/524489
METHODS OF TREATING CANCER Nov 29, 2023 Abandoned
Array ( [id] => 19027264 [patent_doc_number] => 11926611 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-03-12 [patent_title] => 2-(2-ethoxyethoxy)-6-phenyl-4,4'-bipyridine-3-carbonitrile as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/518738 [patent_app_country] => US [patent_app_date] => 2023-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3992 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518738 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/518738
2-(2-ethoxyethoxy)-6-phenyl-4,4'-bipyridine-3-carbonitrile as an antimicrobial compound Nov 23, 2023 Issued
Array ( [id] => 20108179 [patent_doc_number] => 12358885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-15 [patent_title] => Substituted n-propylamine fused heterocyclic mescaline derivatives [patent_app_type] => utility [patent_app_number] => 18/512910 [patent_app_country] => US [patent_app_date] => 2023-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 70 [patent_no_of_words] => 30604 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512910 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/512910
Substituted n-propylamine fused heterocyclic mescaline derivatives Nov 16, 2023 Issued
Array ( [id] => 19717282 [patent_doc_number] => 12202805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-01-21 [patent_title] => Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound [patent_app_type] => utility [patent_app_number] => 18/506737 [patent_app_country] => US [patent_app_date] => 2023-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 68 [patent_no_of_words] => 62809 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506737 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/506737
Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound Nov 9, 2023 Issued
Array ( [id] => 20505890 [patent_doc_number] => 12540157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-03 [patent_title] => Oxysterols and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/388390 [patent_app_country] => US [patent_app_date] => 2023-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95177 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18388390 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/388390
Oxysterols and methods of use thereof Nov 8, 2023 Issued
Array ( [id] => 19065610 [patent_doc_number] => 20240100036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER [patent_app_type] => utility [patent_app_number] => 18/497338 [patent_app_country] => US [patent_app_date] => 2023-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55801 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497338 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/497338
METHODS OF DIAGNOSING AND TREATING ANXIETY DISORDER Oct 29, 2023 Pending
Array ( [id] => 19018851 [patent_doc_number] => 20240075022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER [patent_app_type] => utility [patent_app_number] => 18/497386 [patent_app_country] => US [patent_app_date] => 2023-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59781 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18497386 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/497386
METHODS OF DIAGNOSING AND TREATING CONDUCT DISORDER Oct 29, 2023 Pending
Array ( [id] => 19097702 [patent_doc_number] => 20240116930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => P2X7 MODULATORS [patent_app_type] => utility [patent_app_number] => 18/381554 [patent_app_country] => US [patent_app_date] => 2023-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49318 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18381554 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/381554
P2X7 modulators Oct 17, 2023 Issued
Array ( [id] => 19142123 [patent_doc_number] => 20240140947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => COMPOUND FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 18/488191 [patent_app_country] => US [patent_app_date] => 2023-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18488191 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/488191
COMPOUND FOR THE TREATMENT OF CANCER Oct 16, 2023 Pending
Array ( [id] => 19081821 [patent_doc_number] => 20240108622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/377561 [patent_app_country] => US [patent_app_date] => 2023-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18377561 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/377561
INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF Oct 5, 2023 Abandoned
Array ( [id] => 19217780 [patent_doc_number] => 20240182484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => Crystalline Forms 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)-1H-Pyrazolo[3,4-D]Pyrimidin-1- YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2- Enenitrile [patent_app_type] => utility [patent_app_number] => 18/482278 [patent_app_country] => US [patent_app_date] => 2023-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16052 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18482278 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/482278
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile Oct 5, 2023 Issued
Array ( [id] => 19202736 [patent_doc_number] => 20240174635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => TLR 9 INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/479690 [patent_app_country] => US [patent_app_date] => 2023-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18479690 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/479690
TLR 9 INHIBITORS Oct 1, 2023 Abandoned
Array ( [id] => 19959691 [patent_doc_number] => 12329158 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-17 [patent_title] => Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness [patent_app_type] => utility [patent_app_number] => 18/373376 [patent_app_country] => US [patent_app_date] => 2023-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24425 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 365 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18373376 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/373376
Large-scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness Sep 26, 2023 Issued
Array ( [id] => 19809476 [patent_doc_number] => 12240847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Process for making palbociclib [patent_app_type] => utility [patent_app_number] => 18/474840 [patent_app_country] => US [patent_app_date] => 2023-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3050 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18474840 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/474840
Process for making palbociclib Sep 25, 2023 Issued
Menu